| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 8.34e-08 | 4 | 56 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.93e-06 | 303 | 56 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L NCOR1 ARID1B NANOGP8 UBQLN2 NANOGP1 NANOG KAT6A ARID1A KAT6B MAML3 ZIC3 LAPTM5 | 2.69e-06 | 1160 | 56 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 BCL9L NCOR1 ARID1B NANOGP8 UBQLN2 NANOGP1 NANOG KAT6A ARID1A KAT6B MAML3 ZIC3 LAPTM5 | 1.61e-05 | 1356 | 56 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 2.31e-05 | 3 | 56 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 2.31e-05 | 3 | 56 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.37e-05 | 206 | 56 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.42e-05 | 562 | 56 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 8.04e-05 | 30 | 56 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 8.88e-05 | 31 | 56 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.98e-04 | 739 | 56 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 TBX18 NCOR1 NANOGP8 NANOGP1 NANOG KAT6A ARID1A TP53BP2 | 2.27e-04 | 753 | 56 | 9 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 2.75e-04 | 9 | 56 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.75e-04 | 9 | 56 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 7.92e-04 | 15 | 56 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.02e-03 | 17 | 56 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.28e-03 | 19 | 56 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.37e-03 | 78 | 56 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.88e-03 | 23 | 56 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.88e-03 | 23 | 56 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.40e-03 | 26 | 56 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.95e-03 | 102 | 56 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 3.11e-03 | 104 | 56 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 4.09e-03 | 34 | 56 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 4.45e-03 | 238 | 56 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.65e-03 | 120 | 56 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 5.64e-03 | 582 | 56 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.18e-03 | 417 | 56 | 5 | GO:0061629 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | BCL9L LIG4 BMP7 NANOGP8 NANOGP1 LOXL2 NANOG KAT6A ARID1A ZIC3 | 5.10e-10 | 237 | 54 | 10 | GO:0019827 |
| GeneOntologyBiologicalProcess | maintenance of cell number | BCL9L LIG4 BMP7 NANOGP8 NANOGP1 LOXL2 NANOG KAT6A ARID1A ZIC3 | 6.25e-10 | 242 | 54 | 10 | GO:0098727 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.28e-08 | 108 | 54 | 7 | GO:0035019 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | TBX18 BMP7 NANOGP8 NANOGP1 SLC12A2 NANOG ACTA1 ACTA2 ACTC1 PTCH1 ARID1A ITGAX ZIC3 | 4.90e-08 | 750 | 54 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 6.77e-08 | 4 | 54 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 1.69e-07 | 5 | 54 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.69e-07 | 5 | 54 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 3.37e-07 | 6 | 54 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 9.41e-07 | 8 | 54 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 2.01e-06 | 10 | 54 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 2.76e-06 | 11 | 54 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 7.55e-06 | 15 | 54 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 7.55e-06 | 15 | 54 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 1.12e-05 | 17 | 54 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOA2 TBX18 NCOR1 BMP7 NANOGP8 RESF1 NANOGP1 LOXL2 NANOG KAT6A BEND3 PTCH1 ARID1A KAT6B | 1.14e-05 | 1413 | 54 | 14 | GO:1902679 |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.35e-05 | 18 | 54 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.35e-05 | 18 | 54 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | cell fate specification | 1.74e-05 | 123 | 54 | 5 | GO:0001708 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PHEX TBX18 BMP7 SLC12A2 ABCA12 ACTA1 KAT6A ACTA2 ACTC1 PTCH1 ARID1A ITGAX ZIC3 | 1.76e-05 | 1269 | 54 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 1.81e-05 | 124 | 54 | 5 | GO:0001704 | |
| GeneOntologyBiologicalProcess | gastrulation | 1.88e-05 | 212 | 54 | 6 | GO:0007369 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 2.15e-05 | 594 | 54 | 9 | GO:0007346 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 2.52e-05 | 65 | 54 | 4 | GO:0072132 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 2.89e-05 | 23 | 54 | 3 | GO:0001710 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 4.02e-05 | 4 | 54 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOA2 TBX18 NCOR1 BMP7 NANOGP8 NANOGP1 LOXL2 NANOG KAT6A BEND3 PTCH1 ARID1A KAT6B | 4.90e-05 | 1399 | 54 | 13 | GO:0045892 |
| GeneOntologyBiologicalProcess | mesenchyme development | 5.01e-05 | 372 | 54 | 7 | GO:0060485 | |
| GeneOntologyBiologicalProcess | mesoderm development | 5.61e-05 | 157 | 54 | 5 | GO:0007498 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 5.91e-05 | 29 | 54 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | mesoderm formation | 6.31e-05 | 82 | 54 | 4 | GO:0001707 | |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 7.60e-05 | 86 | 54 | 4 | GO:0048332 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 8.75e-05 | 33 | 54 | 3 | GO:2000737 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | TBX18 BMP7 NANOGP8 NANOGP1 SLC12A2 LOXL2 NANOG ACTA1 ACTC1 PTCH1 ARID1A ITGAX ZIC3 | 8.91e-05 | 1483 | 54 | 13 | GO:0048646 |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 1.00e-04 | 6 | 54 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 1.05e-04 | 35 | 54 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in formation of primary germ layer | 1.24e-04 | 37 | 54 | 3 | GO:0060795 | |
| GeneOntologyBiologicalProcess | response to lipid | NCOA2 PHEX NCOR1 BMP7 NANOGP8 NANOGP1 SLC12A2 NANOG ACTA1 PTCH1 ARID1A | 1.34e-04 | 1126 | 54 | 11 | GO:0033993 |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 1.34e-04 | 38 | 54 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | skeletal muscle thin filament assembly | 1.40e-04 | 7 | 54 | 2 | GO:0030240 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 1.44e-04 | 306 | 54 | 6 | GO:0048863 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.79e-04 | 201 | 54 | 5 | GO:0051302 | |
| GeneOntologyBiologicalProcess | neural plate pattern specification | 2.39e-04 | 9 | 54 | 2 | GO:0060896 | |
| GeneOntologyBiologicalProcess | embryo development | TBX18 NCOR1 LIG4 BMP7 NANOGP8 NANOGP1 NANOG KAT6A PTCH1 ARID1A TP53BP2 ZIC3 | 2.76e-04 | 1437 | 54 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | endoderm formation | 2.87e-04 | 49 | 54 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | stem cell division | 2.87e-04 | 49 | 54 | 3 | GO:0017145 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | BMP7 ARID1B NANOGP8 NANOGP1 ATR NANOG KLHL13 PTCH1 ARID1A TP53BP2 RFWD3 | 3.46e-04 | 1256 | 54 | 11 | GO:0051726 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOA2 TBX18 NCOR1 NANOGP8 NANOGP1 LOXL2 NANOG BEND3 PTCH1 ARID1A | 3.54e-04 | 1053 | 54 | 10 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 3.62e-04 | 53 | 54 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in metanephros development | 3.64e-04 | 11 | 54 | 2 | GO:0072203 | |
| GeneOntologyBiologicalProcess | skeletal myofibril assembly | 3.64e-04 | 11 | 54 | 2 | GO:0014866 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 3.84e-04 | 131 | 54 | 4 | GO:0032526 | |
| GeneOntologyBiologicalProcess | chromatin organization | 4.84e-04 | 896 | 54 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 5.00e-04 | 713 | 54 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | neural plate development | 6.00e-04 | 14 | 54 | 2 | GO:0001840 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 6.01e-04 | 558 | 54 | 7 | GO:0060537 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 6.03e-04 | 63 | 54 | 3 | GO:0010718 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 6.49e-04 | 266 | 54 | 5 | GO:0033044 | |
| GeneOntologyBiologicalProcess | response to ionizing radiation | 6.57e-04 | 151 | 54 | 4 | GO:0010212 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | LIG4 BMP7 UBQLN1 SLC12A2 ATR LOXL2 ACTA1 PTCH1 CDH8 TP53BP2 RFWD3 | 6.82e-04 | 1361 | 54 | 11 | GO:0009628 |
| GeneOntologyBiologicalProcess | heart development | 7.41e-04 | 757 | 54 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 7.42e-04 | 156 | 54 | 4 | GO:0072089 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 7.88e-04 | 421 | 54 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | tube development | PHEX TBX18 BMP7 SLC12A2 ABCA12 LOXL2 KAT6A PTCH1 ARID1A ITGAX ZIC3 | 8.73e-04 | 1402 | 54 | 11 | GO:0035295 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 8.92e-04 | 17 | 54 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 9.03e-04 | 598 | 54 | 7 | GO:0080135 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 1.00e-03 | 18 | 54 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.05e-03 | 999 | 54 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | circulatory system development | TBX18 BMP7 SLC12A2 LOXL2 KAT6A ACTC1 PTCH1 ARID1A ITGAX TP53BP2 ZIC3 | 1.10e-03 | 1442 | 54 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.10e-03 | 619 | 54 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.12e-03 | 78 | 54 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 1.17e-03 | 1014 | 54 | 9 | GO:0000278 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.21e-03 | 80 | 54 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 1.50e-03 | 321 | 54 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | positive regulation of ERAD pathway | 1.50e-03 | 22 | 54 | 2 | GO:1904294 | |
| GeneOntologyBiologicalProcess | locomotor rhythm | 1.50e-03 | 22 | 54 | 2 | GO:0045475 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 1.54e-03 | 190 | 54 | 4 | GO:0016331 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.56e-03 | 324 | 54 | 5 | GO:0006302 | |
| GeneOntologyBiologicalProcess | endoderm development | 1.59e-03 | 88 | 54 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 1.59e-03 | 88 | 54 | 3 | GO:0006289 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.63e-03 | 327 | 54 | 5 | GO:0048738 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 1.75e-03 | 91 | 54 | 3 | GO:0009880 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.76e-03 | 197 | 54 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 1.78e-03 | 1077 | 54 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.88e-03 | 338 | 54 | 5 | GO:0045165 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in kidney development | 1.94e-03 | 25 | 54 | 2 | GO:0072111 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue development | 1.94e-03 | 25 | 54 | 2 | GO:0003228 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 1.94e-03 | 25 | 54 | 2 | GO:0055064 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 2.10e-03 | 26 | 54 | 2 | GO:1902455 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.11e-03 | 347 | 54 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 2.16e-03 | 349 | 54 | 5 | GO:0014706 | |
| GeneOntologyBiologicalProcess | regulation of stem cell differentiation | 2.23e-03 | 99 | 54 | 3 | GO:2000736 | |
| GeneOntologyBiologicalProcess | T cell activation | 2.25e-03 | 701 | 54 | 7 | GO:0042110 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 2.26e-03 | 27 | 54 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.42e-03 | 215 | 54 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.42e-03 | 215 | 54 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 2.43e-03 | 28 | 54 | 2 | GO:0055081 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.54e-03 | 218 | 54 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of ERAD pathway | 2.61e-03 | 29 | 54 | 2 | GO:1904292 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.61e-03 | 29 | 54 | 2 | GO:2000819 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.42e-04 | 7 | 55 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.88e-04 | 8 | 55 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | bBAF complex | 3.02e-04 | 10 | 55 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 TBX18 NCOR1 ARID1B NANOGP8 NANOGP1 LOXL2 NANOG KAT6A BEND3 ARID1A KAT6B | 3.83e-04 | 1480 | 55 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | npBAF complex | 6.06e-04 | 14 | 55 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 6.06e-04 | 14 | 55 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 7.97e-04 | 16 | 55 | 2 | GO:0071565 | |
| HumanPheno | Aspiration pneumonia | 3.26e-05 | 95 | 21 | 5 | HP:0011951 | |
| HumanPheno | Sandal gap | 3.43e-05 | 96 | 21 | 5 | HP:0001852 | |
| HumanPheno | Abnormal toe morphology | LIG4 ARID1B SLC12A2 ATR ABCA12 CPT1C KAT6A ACTA2 PTCH1 ARID1A KAT6B RFWD3 | 4.88e-05 | 893 | 21 | 12 | HP:0001780 |
| HumanPheno | Hip dislocation | 5.62e-05 | 263 | 21 | 7 | HP:0002827 | |
| HumanPheno | Aplasia involving bones of the extremities | LIG4 ARID1B ATR ABCA12 CPT1C KAT6A PTCH1 ARID1A KAT6B RFWD3 ZIC3 | 6.30e-05 | 759 | 21 | 11 | HP:0009825 |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | LIG4 ARID1B ATR ABCA12 CPT1C KAT6A PTCH1 ARID1A KAT6B RFWD3 ZIC3 | 6.46e-05 | 761 | 21 | 11 | HP:0045060 |
| HumanPheno | Joint dislocation | 9.19e-05 | 390 | 21 | 8 | HP:0001373 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | LIG4 ARID1B ATR ABCA12 CPT1C KAT6A PTCH1 ARID1A KAT6B RFWD3 ZIC3 | 1.21e-04 | 813 | 21 | 11 | HP:0009815 |
| HumanPheno | Pneumonia | 1.63e-04 | 311 | 21 | 7 | HP:0002090 | |
| HumanPheno | Lower extremity joint dislocation | 1.88e-04 | 318 | 21 | 7 | HP:0030311 | |
| HumanPheno | Abnormality of the dentition | PHEX LIG4 ARID1B SLC12A2 ATR ABCA12 ACTA1 KAT6A LIPN PTCH1 ARID1A KAT6B | 2.09e-04 | 1030 | 21 | 12 | HP:0000164 |
| HumanPheno | Recurrent infections | PHKB LIG4 ARID1B ATR ABCA12 ACTA1 KAT6A ACTC1 LIPN ARID1A KAT6B RFWD3 | 2.09e-04 | 1030 | 21 | 12 | HP:0002719 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 2.25e-04 | 572 | 21 | 9 | HP:0006496 | |
| HumanPheno | Thin scalp hair | 2.30e-04 | 143 | 21 | 5 | HP:0002556 | |
| HumanPheno | Thin hair | 2.30e-04 | 143 | 21 | 5 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 2.30e-04 | 143 | 21 | 5 | HP:0002209 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 2.71e-04 | 730 | 21 | 10 | HP:0002644 | |
| HumanPheno | Abnormal finger phalanx morphology | 2.97e-04 | 738 | 21 | 10 | HP:0005918 | |
| HumanPheno | Hypoplastic toenails | 3.03e-04 | 82 | 21 | 4 | HP:0001800 | |
| HumanPheno | Abnormality of the urethra | 3.17e-04 | 465 | 21 | 8 | HP:0000795 | |
| HumanPheno | Intestinal malrotation | 3.56e-04 | 157 | 21 | 5 | HP:0002566 | |
| HumanPheno | Unusual infection | PHKB LIG4 ARID1B ATR ABCA12 ACTA1 KAT6A ACTC1 LIPN ARID1A KAT6B RFWD3 | 3.61e-04 | 1088 | 21 | 12 | HP:0032101 |
| HumanPheno | Abnormal sternum morphology | 3.62e-04 | 474 | 21 | 8 | HP:0000766 | |
| HumanPheno | Abnormal spinal cord morphology | 3.85e-04 | 357 | 21 | 7 | HP:0002143 | |
| HumanPheno | Abnormal duodenum morphology | 3.98e-04 | 88 | 21 | 4 | HP:0002246 | |
| HumanPheno | Abnormal pinna morphology | LIG4 ARID1B SLC12A2 ATR ABCA12 ACTA1 KAT6A LIPN PTCH1 ARID1A KAT6B RFWD3 ZIC3 | 4.46e-04 | 1299 | 21 | 13 | HP:0000377 |
| HumanPheno | Hydronephrosis | 5.13e-04 | 264 | 21 | 6 | HP:0000126 | |
| HumanPheno | Spina bifida | 5.28e-04 | 171 | 21 | 5 | HP:0002414 | |
| HumanPheno | Hypospadias | 5.38e-04 | 377 | 21 | 7 | HP:0000047 | |
| HumanPheno | Abnormal thorax morphology | PHEX LIG4 ARID1B SLC12A2 ATR ACTA1 KAT6A ACTA2 ACTC1 PTCH1 ARID1A RFWD3 ZIC3 | 5.63e-04 | 1328 | 21 | 13 | HP:0000765 |
| HumanPheno | Respiratory tract infection | LIG4 ARID1B ABCA12 ACTA1 KAT6A ACTC1 LIPN PTCH1 ARID1A KAT6B | 5.64e-04 | 797 | 21 | 10 | HP:0011947 |
| HumanPheno | Patent ductus arteriosus | 5.83e-04 | 382 | 21 | 7 | HP:0001643 | |
| HumanPheno | Sparse hair | 5.92e-04 | 383 | 21 | 7 | HP:0008070 | |
| HumanPheno | Abnormality of the outer ear | LIG4 ARID1B SLC12A2 ATR ABCA12 ACTA1 KAT6A LIPN PTCH1 ARID1A KAT6B RFWD3 ZIC3 | 6.04e-04 | 1337 | 21 | 13 | HP:0000356 |
| HumanPheno | Abnormal hip bone morphology | 6.19e-04 | 653 | 21 | 9 | HP:0003272 | |
| HumanPheno | Abnormal antihelix morphology | 6.70e-04 | 43 | 21 | 3 | HP:0009738 | |
| HumanPheno | Displacement of the urethral meatus | 7.36e-04 | 397 | 21 | 7 | HP:0100627 | |
| HumanPheno | Abnormality of hair density | 7.48e-04 | 398 | 21 | 7 | HP:0011357 | |
| HumanPheno | Delayed eruption of teeth | 7.58e-04 | 185 | 21 | 5 | HP:0000684 | |
| HumanPheno | Abnormal male urethral meatus morphology | 7.59e-04 | 399 | 21 | 7 | HP:0032076 | |
| HumanPheno | Congenital malformation of the great arteries | 7.65e-04 | 529 | 21 | 8 | HP:0011603 | |
| HumanPheno | Duodenal atresia | 7.67e-04 | 45 | 21 | 3 | HP:0002247 | |
| HumanPheno | Spinal dysraphism | 7.77e-04 | 186 | 21 | 5 | HP:0010301 | |
| HumanPheno | Dilatation of the renal pelvis | 8.47e-04 | 290 | 21 | 6 | HP:0010946 | |
| HumanPheno | Atrial septal defect | 8.90e-04 | 541 | 21 | 8 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 8.90e-04 | 541 | 21 | 8 | HP:0001630 | |
| HumanPheno | Abnormal atrial septum morphology | 9.24e-04 | 544 | 21 | 8 | HP:0011994 | |
| HumanPheno | Abnormality of renal physiology | 9.44e-04 | 691 | 21 | 9 | HP:0000082 | |
| HumanPheno | Abnormal renal pelvis morphology | 1.01e-03 | 300 | 21 | 6 | HP:0010944 | |
| HumanPheno | Short stature | PHEX PHKB LIG4 ARID1B SLC12A1 ATR ABCA12 KAT6A LIPN PTCH1 ARID1A KAT6B RFWD3 | 1.03e-03 | 1407 | 21 | 13 | HP:0004322 |
| HumanPheno | Abnormal lower limb bone morphology | 1.11e-03 | 866 | 21 | 10 | HP:0040069 | |
| MousePheno | abnormal fibrous joint morphology | 2.24e-07 | 135 | 45 | 7 | MP:0030878 | |
| MousePheno | absent primitive endoderm | 2.58e-06 | 9 | 45 | 3 | MP:0011185 | |
| MousePheno | absent extraembryonic ectoderm | 1.38e-05 | 15 | 45 | 3 | MP:0002583 | |
| MousePheno | absent embryonic epiblast | 1.70e-05 | 16 | 45 | 3 | MP:0011184 | |
| MousePheno | abnormal neurocranium morphology | 2.19e-05 | 269 | 45 | 7 | MP:0000074 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TBX18 NCOR1 LIG4 BMP7 ARID1B SLC12A1 ABCA12 ACTA1 KAT6A ACTC1 PTCH1 ARID1A UNC79 TP53BP2 | 2.71e-05 | 1269 | 45 | 14 | MP:0011111 |
| MousePheno | abnormal primitive endoderm morphology | 6.02e-05 | 24 | 45 | 3 | MP:0011183 | |
| MousePheno | increased rhabdomyosarcoma incidence | 6.05e-05 | 4 | 45 | 2 | MP:0002036 | |
| MousePheno | enhanced gluconeogenesis | 6.05e-05 | 4 | 45 | 2 | MP:0030974 | |
| MousePheno | mandibular coronoid process hypoplasia | 6.05e-05 | 4 | 45 | 2 | MP:0030285 | |
| MousePheno | abnormal cranial suture morphology | 6.19e-05 | 67 | 45 | 4 | MP:0002835 | |
| MousePheno | abnormal craniofacial suture morphology | 7.36e-05 | 70 | 45 | 4 | MP:0030229 | |
| MousePheno | increased medulloblastoma incidence | 1.01e-04 | 5 | 45 | 2 | MP:0006283 | |
| MousePheno | abnormal extraembryonic ectoderm morphology | 1.32e-04 | 31 | 45 | 3 | MP:0010736 | |
| MousePheno | abnormal inner cell mass apoptosis | 1.32e-04 | 31 | 45 | 3 | MP:0010380 | |
| MousePheno | abnormal cartilaginous joint morphology | 1.57e-04 | 85 | 45 | 4 | MP:0030875 | |
| MousePheno | disorganized extraembryonic tissue | 1.90e-04 | 35 | 45 | 3 | MP:0002582 | |
| MousePheno | decreased thymus weight | 2.07e-04 | 36 | 45 | 3 | MP:0004956 | |
| MousePheno | abnormal embryonic epiblast morphology | 2.31e-04 | 94 | 45 | 4 | MP:0003886 | |
| MousePheno | abnormal mandible morphology | 2.43e-04 | 176 | 45 | 5 | MP:0000458 | |
| MousePheno | abnormal joint morphology | 2.53e-04 | 397 | 45 | 7 | MP:0002932 | |
| MousePheno | abnormal jaw morphology | 2.53e-04 | 530 | 45 | 8 | MP:0000454 | |
| MousePheno | abnormal chest morphology | 2.63e-04 | 39 | 45 | 3 | MP:0004134 | |
| MousePheno | increased urine creatinine level | 2.80e-04 | 8 | 45 | 2 | MP:0011470 | |
| MousePheno | increased blastoma incidence | 2.80e-04 | 8 | 45 | 2 | MP:0008021 | |
| MousePheno | abnormal bilaminar embryonic disk morphology | 3.16e-04 | 102 | 45 | 4 | MP:0012103 | |
| MousePheno | decreased systemic arterial systolic blood pressure | 3.28e-04 | 42 | 45 | 3 | MP:0006264 | |
| MousePheno | decreased systemic arterial blood pressure | 3.41e-04 | 104 | 45 | 4 | MP:0002843 | |
| MousePheno | small mandibular coronoid process | 3.60e-04 | 9 | 45 | 2 | MP:0030283 | |
| MousePheno | increased muscle tumor incidence | 3.60e-04 | 9 | 45 | 2 | MP:0010290 | |
| MousePheno | palatal shelf hypoplasia | 3.60e-04 | 9 | 45 | 2 | MP:0009883 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 4.52e-04 | 112 | 45 | 4 | MP:0004808 | |
| MousePheno | decreased spleen weight | 4.67e-04 | 113 | 45 | 4 | MP:0004953 | |
| MousePheno | decreased double-negative T cell number | 4.87e-04 | 48 | 45 | 3 | MP:0005089 | |
| MousePheno | abnormal head shape | 4.99e-04 | 115 | 45 | 4 | MP:0011495 | |
| MousePheno | postnatal lethality, complete penetrance | 5.03e-04 | 445 | 45 | 7 | MP:0011085 | |
| MousePheno | abnormal viscerocranium morphology | 5.37e-04 | 593 | 45 | 8 | MP:0005274 | |
| MousePheno | increased brain tumor incidence | 5.47e-04 | 11 | 45 | 2 | MP:0009277 | |
| MousePheno | increased neuronal precursor cell number | 6.55e-04 | 12 | 45 | 2 | MP:0004980 | |
| MousePheno | abnormal gluconeogenesis | 6.89e-04 | 54 | 45 | 3 | MP:0003383 | |
| MousePheno | abnormal ear morphology | 6.96e-04 | 470 | 45 | 7 | MP:0002102 | |
| MousePheno | decreased rib number | 8.08e-04 | 57 | 45 | 3 | MP:0003345 | |
| MousePheno | abnormal Reissner membrane morphology | 9.00e-04 | 14 | 45 | 2 | MP:0006021 | |
| MousePheno | abnormal thymus weight | 9.38e-04 | 60 | 45 | 3 | MP:0004954 | |
| MousePheno | abnormal fetal size | 9.44e-04 | 237 | 45 | 5 | MP:0004198 | |
| MousePheno | abnormal cranium morphology | 9.72e-04 | 813 | 45 | 9 | MP:0000438 | |
| MousePheno | abnormal cricoid cartilage morphology | 1.04e-03 | 15 | 45 | 2 | MP:0002258 | |
| MousePheno | decreased vertebrae number | 1.08e-03 | 63 | 45 | 3 | MP:0004645 | |
| MousePheno | abnormal craniofacial bone morphology | 1.10e-03 | 827 | 45 | 9 | MP:0002116 | |
| MousePheno | abnormal glycogen homeostasis | 1.16e-03 | 144 | 45 | 4 | MP:0005438 | |
| MousePheno | small basisphenoid bone | 1.18e-03 | 16 | 45 | 2 | MP:0004462 | |
| MousePheno | increased incidence of tumors by ionizing radiation induction | 1.18e-03 | 16 | 45 | 2 | MP:0004500 | |
| MousePheno | abnormal intervertebral disk morphology | 1.29e-03 | 67 | 45 | 3 | MP:0004173 | |
| MousePheno | craniorachischisis | 1.34e-03 | 17 | 45 | 2 | MP:0008784 | |
| MousePheno | micrognathia | 1.35e-03 | 68 | 45 | 3 | MP:0002639 | |
| MousePheno | abnormal rib morphology | 1.35e-03 | 257 | 45 | 5 | MP:0000150 | |
| Domain | ACTINS_1 | 1.27e-06 | 8 | 54 | 3 | PS00406 | |
| Domain | BAF250_C | 8.21e-06 | 2 | 54 | 2 | IPR033388 | |
| Domain | BAF250_C | 8.21e-06 | 2 | 54 | 2 | PF12031 | |
| Domain | Ubiquilin-1/2 | 8.21e-06 | 2 | 54 | 2 | IPR028430 | |
| Domain | BAF250/Osa | 8.21e-06 | 2 | 54 | 2 | IPR021906 | |
| Domain | Na/K/Cl_cotranspt | 8.21e-06 | 2 | 54 | 2 | IPR002443 | |
| Domain | Actin_CS | 1.25e-05 | 16 | 54 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.51e-05 | 17 | 54 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.81e-05 | 18 | 54 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.14e-05 | 19 | 54 | 3 | PS01132 | |
| Domain | AA_permease_N | 2.46e-05 | 3 | 54 | 2 | IPR013612 | |
| Domain | AA_permease_N | 2.46e-05 | 3 | 54 | 2 | PF08403 | |
| Domain | MOZ_SAS | 8.16e-05 | 5 | 54 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 8.16e-05 | 5 | 54 | 2 | IPR002717 | |
| Domain | MYST_HAT | 8.16e-05 | 5 | 54 | 2 | PS51726 | |
| Domain | Actin | 9.70e-05 | 31 | 54 | 3 | IPR004000 | |
| Domain | Actin | 9.70e-05 | 31 | 54 | 3 | PF00022 | |
| Domain | ACTIN | 9.70e-05 | 31 | 54 | 3 | SM00268 | |
| Domain | Ubiquilin | 1.22e-04 | 6 | 54 | 2 | IPR015496 | |
| Domain | SLC12A_fam | 1.71e-04 | 7 | 54 | 2 | IPR004842 | |
| Domain | - | 2.09e-04 | 40 | 54 | 3 | 3.40.630.30 | |
| Domain | SLC12_C | 2.27e-04 | 8 | 54 | 2 | IPR018491 | |
| Domain | SLC12 | 2.27e-04 | 8 | 54 | 2 | PF03522 | |
| Domain | Acyl_CoA_acyltransferase | 2.97e-04 | 45 | 54 | 3 | IPR016181 | |
| Domain | STI1 | 3.64e-04 | 10 | 54 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 3.64e-04 | 10 | 54 | 2 | IPR006636 | |
| Domain | H15 | 6.27e-04 | 13 | 54 | 2 | SM00526 | |
| Domain | H15 | 6.27e-04 | 13 | 54 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 7.30e-04 | 14 | 54 | 2 | IPR005818 | |
| Domain | - | 8.41e-04 | 15 | 54 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 8.41e-04 | 15 | 54 | 2 | SM00501 | |
| Domain | ARID_dom | 8.41e-04 | 15 | 54 | 2 | IPR001606 | |
| Domain | ARID | 8.41e-04 | 15 | 54 | 2 | PS51011 | |
| Domain | ARID | 8.41e-04 | 15 | 54 | 2 | PF01388 | |
| Domain | 6-PGluconate_DH_C-like | 1.36e-03 | 19 | 54 | 2 | IPR008927 | |
| Domain | AA-permease/SLC12A_dom | 1.83e-03 | 22 | 54 | 2 | IPR004841 | |
| Domain | AA_permease | 1.83e-03 | 22 | 54 | 2 | PF00324 | |
| Domain | ARM-type_fold | 2.92e-03 | 339 | 54 | 5 | IPR016024 | |
| Domain | UBA | 3.39e-03 | 30 | 54 | 2 | SM00165 | |
| Domain | UBA | 4.85e-03 | 36 | 54 | 2 | PF00627 | |
| Domain | UBIQUITIN_1 | 5.12e-03 | 37 | 54 | 2 | PS00299 | |
| Domain | UBQ | 6.87e-03 | 43 | 54 | 2 | SM00213 | |
| Domain | UBA | 7.18e-03 | 44 | 54 | 2 | IPR015940 | |
| Domain | ubiquitin | 8.16e-03 | 47 | 54 | 2 | PF00240 | |
| Domain | UBA | 8.16e-03 | 47 | 54 | 2 | PS50030 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.81e-05 | 65 | 46 | 4 | M39682 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.37e-04 | 31 | 46 | 3 | M39522 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.16e-04 | 7 | 46 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.16e-04 | 7 | 46 | 2 | MM15081 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.39e-04 | 272 | 46 | 6 | M29619 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 2.53e-04 | 38 | 46 | 3 | M39549 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 4.47e-04 | 46 | 46 | 3 | MM14935 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 4.77e-04 | 47 | 46 | 3 | M39829 | |
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 29079783 | ||
| Pubmed | The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs. | 6.03e-12 | 4 | 56 | 4 | 20872845 | |
| Pubmed | 2.96e-11 | 37 | 56 | 6 | 24335282 | ||
| Pubmed | Hedgehog controls neural stem cells through p53-independent regulation of Nanog. | 9.02e-11 | 6 | 56 | 4 | 20581804 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 30790630 | ||
| Pubmed | Zic3 is required for maintenance of pluripotency in embryonic stem cells. | 2.10e-10 | 7 | 56 | 4 | 17267691 | |
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 16801560 | ||
| Pubmed | H3K27me3 at pericentromeric heterochromatin is a defining feature of the early mouse blastocyst. | 7.55e-10 | 9 | 56 | 4 | 35974030 | |
| Pubmed | 2.95e-09 | 12 | 56 | 4 | 18448678 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 3.95e-09 | 3 | 56 | 3 | 30814124 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 3.95e-09 | 3 | 56 | 3 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 3.95e-09 | 3 | 56 | 3 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 3.95e-09 | 3 | 56 | 3 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 3.95e-09 | 3 | 56 | 3 | 18177668 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 3.95e-09 | 3 | 56 | 3 | 16259959 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 12609610 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 24227785 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 3.95e-09 | 3 | 56 | 3 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 3.95e-09 | 3 | 56 | 3 | 23770853 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 15502159 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 3.95e-09 | 3 | 56 | 3 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 3.95e-09 | 3 | 56 | 3 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 3.95e-09 | 3 | 56 | 3 | 24527385 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 18086680 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 17204467 | ||
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 3.95e-09 | 3 | 56 | 3 | 19800316 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23200040 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 3.95e-09 | 3 | 56 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 3.95e-09 | 3 | 56 | 3 | 23329853 | |
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 3.95e-09 | 3 | 56 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 3.95e-09 | 3 | 56 | 3 | 17352742 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 3.95e-09 | 3 | 56 | 3 | 25005472 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 16773043 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 3.95e-09 | 3 | 56 | 3 | 26733157 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23071603 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 3.95e-09 | 3 | 56 | 3 | 19582141 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21119109 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 32145514 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 19703398 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 3.95e-09 | 3 | 56 | 3 | 18097409 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 3.95e-09 | 3 | 56 | 3 | 28636920 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 3.95e-09 | 3 | 56 | 3 | 25753417 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 20539761 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 18584034 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21969378 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 20661723 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 29245050 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 22337995 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 3.95e-09 | 3 | 56 | 3 | 23333380 | |
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 3.95e-09 | 3 | 56 | 3 | 15494369 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 3.95e-09 | 3 | 56 | 3 | 31891567 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 3.95e-09 | 3 | 56 | 3 | 14728807 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 3.95e-09 | 3 | 56 | 3 | 15916719 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 3.95e-09 | 3 | 56 | 3 | 16845474 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 3.95e-09 | 3 | 56 | 3 | 21194951 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 22388986 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 16313224 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 16791199 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 3.95e-09 | 3 | 56 | 3 | 33665763 | |
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 3.95e-09 | 3 | 56 | 3 | 18024963 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 27125671 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 3.95e-09 | 3 | 56 | 3 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 3.95e-09 | 3 | 56 | 3 | 18436640 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 3.95e-09 | 3 | 56 | 3 | 25410303 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.95e-09 | 3 | 56 | 3 | 7780165 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 33334884 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 3.95e-09 | 3 | 56 | 3 | 33107035 | |
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 3.95e-09 | 3 | 56 | 3 | 17360937 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 35976266 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 3.95e-09 | 3 | 56 | 3 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 3.95e-09 | 3 | 56 | 3 | 30837263 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 3.95e-09 | 3 | 56 | 3 | 27939294 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 24681518 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 26549484 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 18442017 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21187909 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 3.95e-09 | 3 | 56 | 3 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 3.95e-09 | 3 | 56 | 3 | 22142851 | |
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 3.95e-09 | 3 | 56 | 3 | 24462001 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 3.95e-09 | 3 | 56 | 3 | 22172669 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 3.95e-09 | 3 | 56 | 3 | 23103910 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 22315219 | ||
| Pubmed | GATA-1 directly regulates Nanog in mouse embryonic stem cells. | 1.58e-08 | 4 | 56 | 3 | 26296469 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 17518637 | ||
| Pubmed | USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency. | 1.58e-08 | 4 | 56 | 3 | 29263902 | |
| Pubmed | Nanog positively regulates Zfp57 expression in mouse embryonic stem cells. | 1.58e-08 | 4 | 56 | 3 | 25445595 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 19171902 | ||
| Interaction | LHX4 interactions | 1.93e-07 | 166 | 51 | 7 | int:LHX4 | |
| Interaction | YAP1 interactions | BCL9L NCOR1 ARID1B UBQLN2 UBQLN1 ACTA1 ACTA2 ACTC1 BEND3 PTCH1 ARID1A ARHGAP45 TP53BP2 LAPTM5 | 3.51e-07 | 1095 | 51 | 14 | int:YAP1 |
| Interaction | PCYT1B interactions | 4.29e-06 | 13 | 51 | 3 | int:PCYT1B | |
| Interaction | EGR2 interactions | 4.49e-06 | 171 | 51 | 6 | int:EGR2 | |
| Interaction | ETV6 interactions | 6.77e-06 | 105 | 51 | 5 | int:ETV6 | |
| Interaction | KLF5 interactions | 9.53e-06 | 195 | 51 | 6 | int:KLF5 | |
| Interaction | TBR1 interactions | 9.70e-06 | 113 | 51 | 5 | int:TBR1 | |
| Interaction | TPRX2 interactions | 1.21e-05 | 56 | 51 | 4 | int:TPRX2 | |
| Interaction | SMIM2 interactions | 1.88e-05 | 3 | 51 | 2 | int:SMIM2 | |
| Interaction | DEFB115 interactions | 1.88e-05 | 3 | 51 | 2 | int:DEFB115 | |
| Interaction | PAX9 interactions | 1.91e-05 | 130 | 51 | 5 | int:PAX9 | |
| Interaction | NPVF interactions | 3.76e-05 | 4 | 51 | 2 | int:NPVF | |
| Interaction | TLE3 interactions | 4.25e-05 | 376 | 51 | 7 | int:TLE3 | |
| Interaction | CPSF1 interactions | 4.33e-05 | 255 | 51 | 6 | int:CPSF1 | |
| Interaction | CCT5 interactions | 4.78e-05 | 525 | 51 | 8 | int:CCT5 | |
| Interaction | SOX7 interactions | 5.50e-05 | 82 | 51 | 4 | int:SOX7 | |
| Interaction | GUCA2B interactions | 6.25e-05 | 5 | 51 | 2 | int:GUCA2B | |
| Interaction | PHF5A interactions | 7.11e-05 | 171 | 51 | 5 | int:PHF5A | |
| Interaction | SS18 interactions | 7.25e-05 | 88 | 51 | 4 | int:SS18 | |
| Interaction | TLX1 interactions | 7.93e-05 | 175 | 51 | 5 | int:TLX1 | |
| Interaction | SOX10 interactions | 8.62e-05 | 92 | 51 | 4 | int:SOX10 | |
| Interaction | TLX3 interactions | 8.98e-05 | 291 | 51 | 6 | int:TLX3 | |
| Interaction | C1QTNF4 interactions | 9.36e-05 | 6 | 51 | 2 | int:C1QTNF4 | |
| Interaction | SOX17 interactions | 9.77e-05 | 95 | 51 | 4 | int:SOX17 | |
| Interaction | ALG13 interactions | 9.79e-05 | 183 | 51 | 5 | int:ALG13 | |
| Interaction | POU5F1 interactions | 1.01e-04 | 584 | 51 | 8 | int:POU5F1 | |
| Interaction | ABRA interactions | 1.03e-04 | 36 | 51 | 3 | int:ABRA | |
| Interaction | CREBBP interactions | 1.20e-04 | 599 | 51 | 8 | int:CREBBP | |
| Interaction | DNASE1 interactions | 1.31e-04 | 7 | 51 | 2 | int:DNASE1 | |
| Interaction | SMIM19 interactions | 1.31e-04 | 7 | 51 | 2 | int:SMIM19 | |
| Interaction | ZRANB2 interactions | 1.45e-04 | 199 | 51 | 5 | int:ZRANB2 | |
| Interaction | SMARCA4 interactions | 1.54e-04 | 462 | 51 | 7 | int:SMARCA4 | |
| Interaction | FEV interactions | 1.59e-04 | 203 | 51 | 5 | int:FEV | |
| Interaction | GPR162 interactions | 1.74e-04 | 8 | 51 | 2 | int:GPR162 | |
| Interaction | WFDC12 interactions | 1.74e-04 | 8 | 51 | 2 | int:WFDC12 | |
| Interaction | CAP1 interactions | 1.74e-04 | 207 | 51 | 5 | int:CAP1 | |
| Interaction | PAX8 interactions | 1.78e-04 | 111 | 51 | 4 | int:PAX8 | |
| Interaction | SNRNP40 interactions | 1.83e-04 | 637 | 51 | 8 | int:SNRNP40 | |
| Interaction | RESF1 interactions | 1.88e-04 | 44 | 51 | 3 | int:RESF1 | |
| Interaction | BCL7C interactions | 2.04e-04 | 115 | 51 | 4 | int:BCL7C | |
| Interaction | TBXT interactions | 2.11e-04 | 116 | 51 | 4 | int:TBXT | |
| Interaction | PRAM1 interactions | 2.15e-04 | 46 | 51 | 3 | int:PRAM1 | |
| Interaction | RBM17 interactions | 2.22e-04 | 218 | 51 | 5 | int:RBM17 | |
| Interaction | ERG interactions | 2.46e-04 | 223 | 51 | 5 | int:ERG | |
| Interaction | EYA2 interactions | 2.48e-04 | 121 | 51 | 4 | int:EYA2 | |
| Interaction | NCOA3 interactions | 2.51e-04 | 224 | 51 | 5 | int:NCOA3 | |
| Interaction | ACTG2 interactions | 2.59e-04 | 49 | 51 | 3 | int:ACTG2 | |
| Interaction | ANGPTL8 interactions | 2.79e-04 | 10 | 51 | 2 | int:ANGPTL8 | |
| Interaction | PFN3 interactions | 2.79e-04 | 10 | 51 | 2 | int:PFN3 | |
| Interaction | CCT4 interactions | 2.99e-04 | 515 | 51 | 7 | int:CCT4 | |
| Interaction | SMARCB1 interactions | 3.02e-04 | 364 | 51 | 6 | int:SMARCB1 | |
| Interaction | POTEJ interactions | 3.09e-04 | 52 | 51 | 3 | int:POTEJ | |
| Interaction | ACTG1 interactions | 3.17e-04 | 520 | 51 | 7 | int:ACTG1 | |
| Interaction | SEZ6L interactions | 3.40e-04 | 11 | 51 | 2 | int:SEZ6L | |
| Interaction | RTL8A interactions | 3.40e-04 | 11 | 51 | 2 | int:RTL8A | |
| Interaction | PAQR9 interactions | 3.40e-04 | 11 | 51 | 2 | int:PAQR9 | |
| Interaction | WASH8P interactions | 3.40e-04 | 11 | 51 | 2 | int:WASH8P | |
| Interaction | PLAAT3 interactions | 3.40e-04 | 11 | 51 | 2 | int:PLAAT3 | |
| Interaction | SCMH1 interactions | 3.46e-04 | 54 | 51 | 3 | int:SCMH1 | |
| Interaction | TMOD3 interactions | 3.66e-04 | 243 | 51 | 5 | int:TMOD3 | |
| Interaction | POTEE interactions | 3.67e-04 | 134 | 51 | 4 | int:POTEE | |
| Interaction | TP53BP1 interactions | 3.68e-04 | 533 | 51 | 7 | int:TP53BP1 | |
| Interaction | FBXO30 interactions | 3.85e-04 | 56 | 51 | 3 | int:FBXO30 | |
| Interaction | CSNK1A1 interactions | 3.85e-04 | 381 | 51 | 6 | int:CSNK1A1 | |
| Interaction | ZG16 interactions | 4.08e-04 | 12 | 51 | 2 | int:ZG16 | |
| Interaction | FSCN1 interactions | 4.24e-04 | 251 | 51 | 5 | int:FSCN1 | |
| Interaction | SCIN interactions | 4.27e-04 | 58 | 51 | 3 | int:SCIN | |
| Interaction | CRX interactions | 4.48e-04 | 254 | 51 | 5 | int:CRX | |
| Interaction | AFTPH interactions | 4.49e-04 | 59 | 51 | 3 | int:AFTPH | |
| Interaction | FAM168A interactions | 4.57e-04 | 142 | 51 | 4 | int:FAM168A | |
| Interaction | RTL8B interactions | 4.81e-04 | 13 | 51 | 2 | int:RTL8B | |
| Interaction | PPP1R1A interactions | 4.81e-04 | 13 | 51 | 2 | int:PPP1R1A | |
| Interaction | PLAAT2 interactions | 4.81e-04 | 13 | 51 | 2 | int:PLAAT2 | |
| Interaction | SOD3 interactions | 4.81e-04 | 13 | 51 | 2 | int:SOD3 | |
| Interaction | TCP1 interactions | 4.99e-04 | 561 | 51 | 7 | int:TCP1 | |
| Interaction | DHCR24 interactions | 5.07e-04 | 146 | 51 | 4 | int:DHCR24 | |
| Interaction | GC interactions | 5.20e-04 | 62 | 51 | 3 | int:GC | |
| Interaction | CAP2 interactions | 6.24e-04 | 66 | 51 | 3 | int:CAP2 | |
| Interaction | EP300 interactions | NCOA2 NCOR1 UBQLN1 ATR NANOG ACTA1 KAT6A ACTA2 ARID1A SNRPB2 TP53BP2 | 6.32e-04 | 1401 | 51 | 11 | int:EP300 |
| Interaction | FBXO40 interactions | 6.46e-04 | 15 | 51 | 2 | int:FBXO40 | |
| Interaction | NAA80 interactions | 6.46e-04 | 15 | 51 | 2 | int:NAA80 | |
| Interaction | BICRA interactions | 6.53e-04 | 67 | 51 | 3 | int:BICRA | |
| Interaction | WWTR1 interactions | 6.61e-04 | 422 | 51 | 6 | int:WWTR1 | |
| Interaction | NUP35 interactions | 6.77e-04 | 424 | 51 | 6 | int:NUP35 | |
| Interaction | GCM1 interactions | 6.81e-04 | 68 | 51 | 3 | int:GCM1 | |
| Interaction | ETV4 interactions | 7.11e-04 | 69 | 51 | 3 | int:ETV4 | |
| Interaction | PLEC interactions | 7.29e-04 | 430 | 51 | 6 | int:PLEC | |
| Interaction | GUCA2A interactions | 7.37e-04 | 16 | 51 | 2 | int:GUCA2A | |
| Interaction | NAXD interactions | 7.73e-04 | 71 | 51 | 3 | int:NAXD | |
| Interaction | SMARCE1 interactions | 7.78e-04 | 287 | 51 | 5 | int:SMARCE1 | |
| Interaction | MRE11 interactions | 7.78e-04 | 287 | 51 | 5 | int:MRE11 | |
| Interaction | MAP1LC3C interactions | 8.05e-04 | 72 | 51 | 3 | int:MAP1LC3C | |
| Interaction | UBE3A interactions | 8.31e-04 | 441 | 51 | 6 | int:UBE3A | |
| Interaction | REG3A interactions | 8.33e-04 | 17 | 51 | 2 | int:REG3A | |
| Interaction | ANKRD33 interactions | 8.33e-04 | 17 | 51 | 2 | int:ANKRD33 | |
| Interaction | COL9A2 interactions | 8.33e-04 | 17 | 51 | 2 | int:COL9A2 | |
| Interaction | CTSD interactions | 8.39e-04 | 167 | 51 | 4 | int:CTSD | |
| Interaction | ACTN2 interactions | 9.17e-04 | 171 | 51 | 4 | int:ACTN2 | |
| Interaction | NPY interactions | 9.36e-04 | 18 | 51 | 2 | int:NPY | |
| Interaction | SERPINI2 interactions | 9.36e-04 | 18 | 51 | 2 | int:SERPINI2 | |
| Cytoband | 15q14 | 3.04e-05 | 49 | 56 | 3 | 15q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q14 | 5.88e-05 | 61 | 56 | 3 | chr15q14 | |
| GeneFamily | Actins | 2.32e-07 | 6 | 42 | 3 | 929 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.75e-06 | 17 | 42 | 3 | 486 | |
| GeneFamily | Ubiquilin family | 5.24e-05 | 5 | 42 | 2 | 783 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 5.04e-04 | 67 | 42 | 3 | 519 | |
| GeneFamily | AT-rich interaction domain containing | 5.43e-04 | 15 | 42 | 2 | 418 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 6.19e-04 | 16 | 42 | 2 | 66 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 6.25e-03 | 51 | 42 | 2 | 870 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.51e-03 | 181 | 42 | 3 | 694 | |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 1.36e-08 | 14 | 52 | 4 | MM810 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 8.75e-07 | 10 | 52 | 3 | MM741 | |
| Coexpression | BENPORATH_NOS_TARGETS | 1.46e-06 | 179 | 52 | 6 | M14573 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 2.70e-06 | 199 | 52 | 6 | M4444 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 4.94e-06 | 125 | 52 | 5 | MM1065 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 2.31e-05 | 290 | 52 | 6 | M17183 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 2.89e-05 | 180 | 52 | 5 | M8906 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 4.78e-05 | 200 | 52 | 5 | M7831 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 4.78e-05 | 200 | 52 | 5 | M4449 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.20e-04 | 48 | 52 | 3 | M1568 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.27e-04 | 49 | 52 | 3 | MM1178 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 1.34e-04 | 131 | 52 | 4 | M39232 | |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_UP | 1.34e-04 | 131 | 52 | 4 | M437 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOR1 SYNRG TBC1D4 RESF1 ATR KAT6A ARID1A KAT6B ARHGAP45 SMAP2 LAPTM5 | 1.36e-04 | 1492 | 52 | 11 | M40023 |
| Coexpression | WINTER_HYPOXIA_DN | 1.52e-04 | 52 | 52 | 3 | M2683 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 1.86e-04 | 267 | 52 | 5 | MM984 | |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 2.10e-04 | 11 | 52 | 2 | M1922 | |
| Coexpression | ISSAEVA_MLL2_TARGETS | 2.44e-04 | 61 | 52 | 3 | M2281 | |
| Coexpression | GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 2.55e-04 | 155 | 52 | 4 | M8913 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 3.46e-05 | 26 | 52 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 4.35e-05 | 28 | 52 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.89e-06 | 177 | 56 | 5 | fcf9138eb95de554fa70243ff282cb4c54c1d3fc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 191 | 56 | 5 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.30e-06 | 192 | 56 | 5 | 5ea1a8119012eb8bc3100b739a0430377a8ac534 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 195 | 56 | 5 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 5.12e-06 | 199 | 56 | 5 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 5.12e-06 | 199 | 56 | 5 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-05 | 155 | 56 | 4 | 231fbbbd6e6f9c86be7a15a9ec0804e6b9ab3b5f | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.66e-05 | 158 | 56 | 4 | f366c3532e7ef591e1051c172c92db41eb8c57f0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.65e-05 | 166 | 56 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-05 | 166 | 56 | 4 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-05 | 166 | 56 | 4 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 173 | 56 | 4 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 173 | 56 | 4 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | 9019011eb8d9b7a95804fc11434f0fd42418103a | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | deafbd0c2523afe09cc42f8c7b33945f3f5c00b4 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | f2eb0199f59e1e2f46da344c05289876bd254fa3 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 175 | 56 | 4 | c9dc6aa652ac887470806a950311657c423d9495 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 176 | 56 | 4 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.41e-05 | 178 | 56 | 4 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-05 | 181 | 56 | 4 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-05 | 181 | 56 | 4 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-05 | 183 | 56 | 4 | f524501dec1dccbf44100a61395116e4525bdc89 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.42e-05 | 184 | 56 | 4 | 7d9294e5a55964903feda135e5bea0338824ed83 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | 7acc071ea75442817db4d98bd3ed3fff6f0a9d46 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 8.78e-05 | 186 | 56 | 4 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.78e-05 | 186 | 56 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 8.96e-05 | 187 | 56 | 4 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-05 | 187 | 56 | 4 | 39756ab418267151d86f9c2553db859f71900bb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.53e-05 | 190 | 56 | 4 | b7ce76931edc6734b80ddbb2fca23b098a8c1352 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.73e-05 | 191 | 56 | 4 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.73e-05 | 191 | 56 | 4 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.92e-05 | 192 | 56 | 4 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.92e-05 | 192 | 56 | 4 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 193 | 56 | 4 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 193 | 56 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 193 | 56 | 4 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 193 | 56 | 4 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 194 | 56 | 4 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 194 | 56 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 194 | 56 | 4 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 195 | 56 | 4 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 195 | 56 | 4 | 8ae2886dd4cfc70c58b61fbb6994f0a22f8c9127 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 195 | 56 | 4 | e17d05b9ef5e63b49385ddb2fbdc2ade9ea8723f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 196 | 56 | 4 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 196 | 56 | 4 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | control-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.07e-04 | 196 | 56 | 4 | 10d914f1612622f64ac71da04e1995a854a4bec9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 196 | 56 | 4 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 196 | 56 | 4 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 196 | 56 | 4 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 197 | 56 | 4 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 197 | 56 | 4 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 197 | 56 | 4 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 197 | 56 | 4 | c6e977adb1248957d31300312310e08238b64236 | |
| ToppCell | distal-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-04 | 197 | 56 | 4 | 9a1c9221904ad1e46e64e3785516804e87128adc | |
| ToppCell | NS-critical-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-04 | 197 | 56 | 4 | f38037dfa6c33e9336130d0cc65eaba0f120efb9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 197 | 56 | 4 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-04 | 198 | 56 | 4 | 00a54af5267bfe0eeab6720bf890dc4b6b803bfd | |
| ToppCell | proximal-Hematologic-Classical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 198 | 56 | 4 | 6a7ca6eef6b74aa7fc3aec84e9ffd0beedaa589b | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 198 | 56 | 4 | 67e297b3f305d136ff586f68b618e25c902dbcb7 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 198 | 56 | 4 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.12e-04 | 198 | 56 | 4 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 198 | 56 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.12e-04 | 198 | 56 | 4 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 4ba72ba1f0cebc93053aae72d763c33e155b6fa4 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 198 | 56 | 4 | cb177bad587de804f98b38502a284dc267e37aff | |
| ToppCell | Kidney-Leukocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.12e-04 | 198 | 56 | 4 | 4050553f292ce00d547bc79207d6b9a44f4db34f | |
| ToppCell | proximal-3-Hematologic-Classical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 198 | 56 | 4 | 6c6a63b8ec03b7a8f46b70bf13261fab56355f92 | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-04 | 198 | 56 | 4 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | proximal-Hematologic-Classical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 198 | 56 | 4 | 98bd2b3e03ab659ce163d5773660ce008e4cc2ca | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 199 | 56 | 4 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 199 | 56 | 4 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 56 | 4 | e12cea071e46436835cc22fe7badcbe878a1305b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 56 | 4 | 2ff5007b971c6fca9a9ef433e257739f0322a2a5 | |
| ToppCell | cellseq2-Immune|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-04 | 199 | 56 | 4 | 631f29931d102ea308088809a05281588c9c9e3d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 199 | 56 | 4 | 87c7b8c77c28f3cfa6d6dddfd00c9d18d116207e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 5ea3e74687893b8ca6cb915f0f14a14d4692775c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| Computational | Muscle genes. | 1.58e-04 | 37 | 31 | 3 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 3.66e-04 | 49 | 31 | 3 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 4.12e-04 | 51 | 31 | 3 | MODULE_329 | |
| Drug | SIRIUS | 2.48e-08 | 77 | 53 | 6 | CID000091750 | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.49e-06 | 192 | 53 | 6 | 6207_DN | |
| Drug | blebbistatin | 7.43e-06 | 116 | 53 | 5 | CID003476986 | |
| Drug | Nsc687160 | 9.48e-06 | 18 | 53 | 3 | CID005459290 | |
| Drug | tolytoxin | 1.12e-05 | 19 | 53 | 3 | CID006440827 | |
| Drug | m2-19 | 1.12e-05 | 19 | 53 | 3 | CID000079129 | |
| Drug | AC1L8NVR | 1.54e-05 | 21 | 53 | 3 | CID000384633 | |
| Drug | NSC312786 | 1.54e-05 | 21 | 53 | 3 | CID000329495 | |
| Drug | bromide;iodide | 1.59e-05 | 3 | 53 | 2 | CID009907214 | |
| Drug | L-Carnosine | 2.53e-05 | 73 | 53 | 4 | CID000009369 | |
| Drug | carbodiimide | 2.67e-05 | 151 | 53 | 5 | CID000009864 | |
| Drug | CID5288653 | 3.74e-05 | 28 | 53 | 3 | CID005288653 | |
| Drug | azaspiracid | 4.63e-05 | 30 | 53 | 3 | CID006451158 | |
| Drug | khellin | 4.83e-05 | 171 | 53 | 5 | CID000003828 | |
| Drug | Quinethazone | 5.29e-05 | 5 | 53 | 2 | DB01325 | |
| Drug | Bumetanide | 5.29e-05 | 5 | 53 | 2 | DB00887 | |
| Drug | AC1L1HS4 | 5.63e-05 | 32 | 53 | 3 | CID000004267 | |
| Drug | AC1L1COZ | 5.76e-05 | 90 | 53 | 4 | CID000001996 | |
| Drug | polyproline | 6.19e-05 | 295 | 53 | 6 | CID000439587 | |
| Drug | lithium chromate | 6.31e-05 | 296 | 53 | 6 | CID000026627 | |
| Drug | N,N'-p-phenylenedimaleimide | 6.77e-05 | 34 | 53 | 3 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 6.77e-05 | 34 | 53 | 3 | CID000001312 | |
| Drug | Aspidium | 6.84e-05 | 184 | 53 | 5 | CID000000815 | |
| Drug | indium oxide | 7.93e-05 | 6 | 53 | 2 | CID000150905 | |
| Drug | Potassium Chloride | 7.93e-05 | 6 | 53 | 2 | DB00761 | |
| Drug | NSC3096 | 8.04e-05 | 98 | 53 | 4 | CID000002832 | |
| Drug | AC1NSKFN | 8.05e-05 | 36 | 53 | 3 | CID005311324 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 6999_UP | |
| Drug | glutamin | 9.19e-05 | 461 | 53 | 7 | CID000000738 | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 4505_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; HL60; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 1300_UP | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 7203_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.01e-04 | 200 | 53 | 5 | 3907_DN | |
| Drug | CID6432277 | 1.19e-04 | 41 | 53 | 3 | CID006432277 | |
| Drug | epsilon-ATP | 1.19e-04 | 41 | 53 | 3 | CID000162262 | |
| Drug | bumetanide | 1.25e-04 | 209 | 53 | 5 | CID000002471 | |
| Drug | monoisoamyl-2,3-dimercaptosuccinate | 1.28e-04 | 42 | 53 | 3 | ctd:C091888 | |
| Drug | AC1L8FNU | 1.47e-04 | 44 | 53 | 3 | CID000425429 | |
| Drug | AC1LCVO8 | 1.48e-04 | 8 | 53 | 2 | CID000656891 | |
| Drug | alpha-lapachone | 1.48e-04 | 8 | 53 | 2 | CID000072732 | |
| Drug | B0683 | 1.60e-04 | 117 | 53 | 4 | CID006398969 | |
| Drug | Pb m | 1.65e-04 | 118 | 53 | 4 | CID006327255 | |
| Drug | NpCaM | 1.91e-04 | 48 | 53 | 3 | CID000122259 | |
| Drug | AC1Q6LQU | 1.91e-04 | 48 | 53 | 3 | CID000072380 | |
| Drug | NSC106399 | 2.29e-04 | 51 | 53 | 3 | CID000002887 | |
| Drug | NSC613009 | 2.39e-04 | 130 | 53 | 4 | CID000003800 | |
| Disease | colon cancer (implicated_via_orthology) | 2.59e-09 | 11 | 51 | 4 | DOID:219 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 2.71e-07 | 8 | 51 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 2.71e-07 | 8 | 51 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 2.71e-07 | 8 | 51 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 2.71e-07 | 8 | 51 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 5.79e-07 | 10 | 51 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 5.79e-07 | 10 | 51 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 8.78e-06 | 3 | 51 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.92e-05 | 5 | 51 | 2 | C3281201 | |
| Disease | Breast Carcinoma | 3.72e-05 | 538 | 51 | 7 | C0678222 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 4.37e-05 | 6 | 51 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.95e-05 | 41 | 51 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.95e-05 | 41 | 51 | 3 | C0858252 | |
| Disease | Malignant neoplasm of breast | 8.33e-05 | 1074 | 51 | 9 | C0006142 | |
| Disease | Prostatic Neoplasms | 8.72e-05 | 616 | 51 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.72e-05 | 616 | 51 | 7 | C0376358 | |
| Disease | neuroblastoma (is_implicated_in) | 1.31e-04 | 10 | 51 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Congenital ichthyosis of skin | 1.59e-04 | 11 | 51 | 2 | cv:C0020758 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 1.59e-04 | 11 | 51 | 2 | C0079154 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 2.26e-04 | 13 | 51 | 2 | C0265338 | |
| Disease | precuneus cortex volume measurement | 2.63e-04 | 14 | 51 | 2 | EFO_0010326 | |
| Disease | Situs ambiguus | 3.03e-04 | 15 | 51 | 2 | C0266642 | |
| Disease | Chronic myeloproliferative disorder | 4.92e-04 | 19 | 51 | 2 | C1292778 | |
| Disease | Seckel syndrome | 6.62e-04 | 22 | 51 | 2 | C0265202 | |
| Disease | progranulin measurement | 6.62e-04 | 22 | 51 | 2 | EFO_0004625 | |
| Disease | Adenoid Cystic Carcinoma | 6.99e-04 | 100 | 51 | 3 | C0010606 | |
| Disease | unipolar depression, depressive symptom measurement | 9.27e-04 | 26 | 51 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.24e-03 | 30 | 51 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 1.43e-03 | 128 | 51 | 3 | C0006826 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.51e-03 | 286 | 51 | 4 | EFO_0004346, EFO_0006930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTQIMFETFNVPAMY | 121 | P68133 | |
| LMFTNIMMQNTNPSA | 1311 | Q86UK0 | |
| IMMQNTNPSASPEYM | 1316 | Q86UK0 | |
| MTQIMFETFNVPAMY | 121 | P62736 | |
| MTQGQMPNSSMQDMY | 1366 | Q8NFD5 | |
| MPNSSMQDMYNQSPS | 1371 | Q8NFD5 | |
| MQDMYNQSPSGAMSN | 1376 | Q8NFD5 | |
| LSYFDKMSNEMPMTL | 856 | A2RUS2 | |
| HNSAPMFMLDLYNAM | 76 | P18075 | |
| MMPMFLTVYLSNNEQ | 1 | Q13625 | |
| MLSTANMKSSQYIPM | 481 | Q6PCD5 | |
| MSPTFINMSQENVDM | 386 | P20702 | |
| MNTLNAMNGYSMSQP | 1986 | Q8WYB5 | |
| GYMNQTPQYPMQMQM | 2011 | Q8WYB5 | |
| IQKMFYMLNTLTSNM | 196 | Q5T5X7 | |
| YQPSMNTSDMMGRMS | 1211 | O14497 | |
| MNQSRMDVYMSHAPT | 271 | Q5VXI9 | |
| TISYYQMMHMQTAPL | 506 | Q92619 | |
| MYNMSTGMTQMLQHP | 871 | Q96JK9 | |
| MVQQTTYLEDRPMFM | 556 | Q9Y4K0 | |
| SPMYFFISQLSLMDM | 61 | Q6IEZ7 | |
| TPQTMDLFLNYSMNM | 286 | Q9H9S0 | |
| SPMYFFISQLSLMDM | 61 | Q8NH02 | |
| MNTLNAMNSYRMTQP | 1916 | Q92794 | |
| AMNSYRMTQPMMNSS | 1921 | Q92794 | |
| RMTQPMMNSSYHSNP | 1926 | Q92794 | |
| MMNSSYHSNPAYMNQ | 1931 | Q92794 | |
| AYMNQTAQYPMQMQM | 1941 | Q92794 | |
| NPLMVNSNYYMMDFL | 246 | Q8TCG5 | |
| MGYLQSAPLQLMSMQ | 186 | Q13535 | |
| LLLEASNYQMMPYMQ | 311 | Q9P2N7 | |
| SNYQMMPYMQPVMQS | 316 | Q9P2N7 | |
| EMMAYNPNTQTFMQK | 331 | P49917 | |
| YASMIPLQMMQNYLR | 1101 | Q8WZ74 | |
| QNYSEGMMLQEQLPM | 296 | A0A1W2PPK0 | |
| QNPLSLMMTQMSKYA | 1081 | Q86UU0 | |
| NMSYNMSLMYLISGP | 81 | Q8IXH8 | |
| PMNLFIMYMAGNTIS | 81 | Q5J8M3 | |
| CIYMAPMNQSQVLMS | 26 | P55286 | |
| ETNEMMLSMLFNQFP | 161 | P08579 | |
| QPTLSDMTMYEMNFS | 966 | Q93100 | |
| YNSLSMAMQTLKHMP | 146 | Q6P1K8 | |
| AMYFSNMTVTMVANL | 171 | P59537 | |
| MNYSSQMSQGPIAMQ | 66 | Q9UMZ2 | |
| SMNHMNYLPSQEDMP | 166 | Q13571 | |
| TYSMQMQMIPSNSTR | 161 | Q9HCM1 | |
| TPQTMDLFLNYSMNM | 286 | Q6NSW7 | |
| VSYQNTMSRGSPMMN | 1486 | O75376 | |
| QTMFQLMTPKQMYEH | 361 | Q13635 | |
| VSQMGMRQTSMDYFQ | 516 | Q86VE3 | |
| QYGLMNNFQVMSMVS | 476 | Q13621 | |
| MTQIMFETFNVPAMY | 121 | P68032 | |
| MNSAAPSNKDMYTEM | 156 | B2RD01 | |
| TSMYSNNMNINVSMA | 1381 | Q15596 | |
| FPNYSPMNMNMGVNV | 216 | O60481 | |
| TQAMFMAPAQMAYPT | 281 | Q8WU79 | |
| SMQISGMSPQLQYIM | 486 | O95935 | |
| ENPQLMQNMLSAPYM | 386 | Q9UMX0 | |
| SAPYMRSMMQSLSQN | 396 | Q9UMX0 | |
| PCSYGLMNNFQVMSM | 581 | P55011 | |
| MYNKMNISELSAMIP | 296 | P78562 | |
| MTSYNCSYNIPMMAV | 881 | Q86WI1 | |
| PDMMSLQIQMYQLSR | 1046 | O60343 | |
| FNTPQTMDLFLNYSM | 211 | Q8N7R0 | |
| TMDLFLNYSMNMQPE | 216 | Q8N7R0 | |
| QLIQNMLSAPYMRSM | 381 | Q9UHD9 | |
| YMRSMMQSLSQNPDL | 391 | Q9UHD9 | |
| QSRFSMMPQSMANSS | 206 | Q8IZJ6 | |
| MLMIAMQYTSNPVYH | 226 | Q9P2D8 |